EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tirzepatide Attenuates Cortical Inflammatory and Neuronal Alterations in Diabetic Rats: Associations with PI3K/AKT Phosphorylation and Conditioned Fear Responses

Min Lei, Yuqing Zhang, Mingjing Chen, Xiufen Liu, Changhan Ouyang, Xiaosong Yang, Qingjie Chen, Xiying Guo

Pharmaceuticals · 19.11.2026 · 19 (11) · 1841

DOI: 10.3390/ph19111841 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.11.2026. Verfasst von Min Lei und 7 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Tirzepatide lowers blood glucose, but its effects on diabetes-associated neurological dysfunction remain incompletely characterized. We examined conditioned fear responses and accompanying prefrontal cortical alterations in diabetic rats.

Methods

Male Sprague Dawley rats with diabetes induced by a high-fat diet and streptozotocin received tirzepatide (1.35 mg/kg intraperitoneally, twice weekly) for 10 weeks. Metabolic and behavioral assessments included eight rats per group. Neuronal morphology, synapse-associated proteins, tau phosphorylation, inflammatory cytokines, PI3K/AKT phosphorylation, and autophagy-related proteins were examined in prefrontal cortical tissue.

Results

Tirzepatide treatment was associated with improved glycemic control and oral glucose tolerance. The insulin-tolerance-test area under the curve did not differ significantly between treated and untreated diabetic rats (adjusted p = 0.0993). Treated diabetic rats showed higher freezing at 96 h (adjusted p = 0.0017), although the group-by-time interaction was not significant (p = 0.1308). Treatment was associated with fewer neurons showing degeneration-like morphology, higher PSD95 and SYT1 abundance, and lower tau phosphorylation at Thr205 and Ser404. Prefrontal cortical TNF-α, IL-6, and IL-1β expression decreased. Prefrontal cortical TNF-α and IL-1β mRNA levels and protein concentrations of TNF-α, IL-6, and IL-1β were lower following tirzepatide treatment, whereas the reduction in IL-6 mRNA was not statistically significant. PI3K/AKT phosphorylation and the abundance of autophagy-related proteins were also altered.

Conclusions

The findings link tirzepatide treatment to metabolic, behavioral, inflammatory, and neuronal changes in diabetic rats. They do not establish PI3K/AKT causality, restored autophagic flux, or restored long-term memory. Direct central effects cannot be separated from the consequences of improved systemic metabolism. Initial conditioning differences and the absence of independent locomotor and shock-sensitivity assessments limit the behavioral interpretation. Nissl morphology and synaptic protein abundance do not independently establish neuronal viability or improved synaptic function.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Lei, M., Zhang, Y., Chen, M., Liu, X., Ouyang, C., Yang, X., Chen, Q., & Guo, X. (2026). Tirzepatide Attenuates Cortical Inflammatory and Neuronal Alterations in Diabetic Rats: Associations with PI3K/AKT Phosphorylation and Conditioned Fear Responses. Pharmaceuticals, 19(11), 1841. https://doi.org/10.3390/ph19111841

Vancouver

Lei M, Zhang Y, Chen M, Liu X, Ouyang C, Yang X, et al. Tirzepatide Attenuates Cortical Inflammatory and Neuronal Alterations in Diabetic Rats: Associations with PI3K/AKT Phosphorylation and Conditioned Fear Responses. Pharmaceuticals. 2026;19(11):1841. doi:10.3390/ph19111841

BibTeX
@article{Lei2026,
  author = {Lei, Min and Zhang, Yuqing and Chen, Mingjing and Liu, Xiufen and Ouyang, Changhan and Yang, Xiaosong and Chen, Qingjie and Guo, Xiying},
  title = {Tirzepatide Attenuates Cortical Inflammatory and Neuronal Alterations in Diabetic Rats: Associations with PI3K/AKT Phosphorylation and Conditioned Fear Responses},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1841},
  doi = {10.3390/ph19111841}
}
Kostenlos starten →